Kaiser Permanente
Division of Research Spotlight

The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.

Study Finds Wide Variations In Projected Heart Benefits Of Anti-Blood-Clotting Medications For People With Atrial Fibrillation

Study Finds Wide Variations in Projected Heart Benefits of Anti-Blood-Clotting Medications for People with Atrial Fibrillation

The reported rates of ischemic stroke in four large studies vary substantially, creating uncertainty about the predicted benefits of anticoagulation medication, according to new findings in Annals of Internal Medicine by Kaiser Permanente researchers and colleagues.
Read More
New Research Does Not Find Elevated Risk Of Serious Cardiovascular Events Associated With Use Of ADHD Medications In Young And Middle-aged Adults

New Research Does Not Find Elevated Risk of Serious Cardiovascular Events Associated with Use of ADHD Medications in Young and Middle-aged Adults

In a recently published study, Division researchers found little evidence of increased risk of heart attack, sudden cardiac death or stroke associated with use of medications used primarily used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). The population-based study included more than…

Read More
Study Finds That Patients Using Statins For The First Time, And Who Used Mail-order Pharmacies, Are More Likely To Have Good Cholesterol Control

Study finds that patients using statins for the first time, and who used mail-order pharmacies, are more likely to have good cholesterol control

Patients at Kaiser Permanente Northern California who got their new statin prescriptions from mail-order pharmacies showed better cholesterol control, in the first three to 15 months after starting therapy, than patients using walk-in pharmacies, according to a Kaiser Permanente Northern…

Read More